ChatGPT in glioma adjuvant therapy decision making: ready to assume the role of a doctor in the tumour board?
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Objective: To evaluate ChatGPT‘s performance in brain glioma adjuvant therapy decision-making. Methods: We randomly selected 10 patients with brain gliomas discussed at our institution’s central nervous system tumour board (CNS TB). Patients’ clinical status, surgical outcome, textual imaging information and immuno-pathology results were provided to ChatGPT V.3.5 and seven CNS tumour experts. The chatbot was asked to give the adjuvant treatment choice, and the regimen while considering the patient’s functional status. The experts rated the artificial intelligence-based recommendations from 0 (complete disagreement) to 10 (complete agreement). An intraclass correlation coefficient agreement (ICC) was used to measure the inter-rater agreement. Results: Eight patients (80%) met the criteria for glioblastoma and two (20%) were low-grade gliomas. The experts rated the quality of ChatGPT recommendations as poor for diagnosis (median 3, IQR 1–7.8, ICC 0.9, 95% CI 0.7 to 1.0), good for treatment recommendation (7, IQR 6–8, ICC 0.8, 95% CI 0.4 to 0.9), good for therapy regimen (7, IQR 4–8, ICC 0.8, 95% CI 0.5 to 0.9), moderate for functional status consideration (6, IQR 1–7, ICC 0.7, 95% CI 0.3 to 0.9) and moderate for overall agreement with the recommendations (5, IQR 3–7, ICC 0.7, 95% CI 0.3 to 0.9). No differences were observed between the glioblastomas and low-grade glioma ratings. Conclusions: ChatGPT performed poorly in classifying glioma types but was good for adjuvant treatment recommendations as evaluated by CNS TB experts. Even though the ChatGPT lacks the precision to replace expert opinion, it may serve as a promising supplemental tool within a human-in-the-loop approach.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A guideline of selecting and reporting intraclass correlation coefficients for reliability research
Koo, T. K., & Li, M. Y. (2016) · Journal of Chiropractic Medicine · doi:10.1016/j.jcm.2016.02.012 · Cited by 31,709
BioBERT: a pre-trained biomedical language representation model for biomedical text mining
Lee, J., Yoon, W., Kim, S., Kim, D., Kim, S., So, C. H., & Kang, J. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btz682 · Cited by 7,218
Stupp, R., Taillibert, S., Kanner, A., Read, W., Steinberg, D. M., Lhermitte, B., Toms, S., Idbaih, A., Ahluwalia, M. S., Fink, K., et al. (2017) · JAMA · doi:10.1001/jama.2017.18718 · Cited by 2,644
Artificial intelligence in medicine
Hamet, P., & Tremblay, J. (2017) · Metabolism · doi:10.1016/j.metabol.2017.01.011 · Cited by 2,334
ChatGPT: five priorities for research
van Dis, E. A. M., Bollen, J., Zuidema, W., van Rooij, R., & Bockting, C. L. (2023) · Nature · doi:10.1038/d41586-023-00288-7 · Cited by 1,842
Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine
Lee, P., Bubeck, S., & Petro, J. (2023) · New England Journal of Medicine · doi:10.1056/nejmsr2214184 · Cited by 1,738
ChatGPT is fun, but not an author
Thorp, H. H. (2023) · Science · doi:10.1126/science.adg7879 · Cited by 1,437
Artificial Intelligence in Cancer Research and Precision Medicine
Bhinder, B., Gilvary, C., Madhukar, N. S., & Elemento, O. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0090 · Cited by 781
Pillay, B., Wootten, A. C., Crowe, H., Corcoran, N., Tran, B., Bowden, P., Crowe, J., & Costello, A. J. (2016) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2015.11.007 · Cited by 704
Tools such as ChatGPT threaten transparent science; here are our ground rules for their use
(2023) · Nature · doi:10.1038/d41586-023-00191-1 · Cited by 605
Cited by
Leveraging large language models for decision support in personalized oncology
Benary, M., Wang, X. D., Schmidt, M., Soll, D., Hilfenhaus, G., Nassir, M., Sigler, C., Knödler, M., Keller, U., Beule, D., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.43689 · Cited by 306
Large Language Models for Chatbot Health Advice Studies: A Systematic Review
Huo, B., Boyle, A., Marfo, N., Tangamornsuksan, W., Steen, J. P., McKechnie, T., Lee, Y., Mayol, J., Antoniou, S. A., Thirunavukarasu, A. J., et al. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.57879 · Cited by 283
Assessing the research landscape and clinical utility of large language models: a scoping review
Park, Y.-J., Pillai, A., Deng, J., Guo, E., Gupta, M., Paget, M., & Naugler, C. (2024) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-024-02459-6 · Cited by 187
Applications of large language models in cancer care: current evidence and future perspectives
Iannantuono, G. M., Bracken-Clarke, D., Floudas, C. S., Roselli, M., Gulley, J. L., & Karzai, F. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1268915 · Cited by 115
Clinical and Surgical Applications of Large Language Models: A Systematic Review
Pressman, S. M., Borna, S., Gomez-Cabello, C. A., Haider, S. A., Haider, C. R., & Forte, A. J. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13113041 · Cited by 107
Metadata
- Authors
- Haemmerli, J., Sveikata, L., Nouri, A., May, A., Egervari, K., Freyschlag, C., Lobrinus, J. A., Migliorini, D., Momjian, S., Sanda, N., Schaller, K., Tran, S., Yeung, J., & Bijlenga, P.
- Venue
- BMJ Health & Care Informatics
- Publisher
- BMJ
- Published
- 2023-06
- Volume
- 30
- Issue
- 1
- Pages
- e100775
- ISSN
- 2632-1009 (ISSN-L)
- OpenAlex
- W4383059305
- Cited by
- 100
- References
- 17
- FWCI
- 3.46
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: ChatGPT in glioma adjuvant therapy decision making: ready to assume the role of a doctor in the tumour board? https://app.cochat.ai/papers/10.1136/bmjhci-2023-100775
- The paper
- Haemmerli, J., Sveikata, L., Nouri, A., May, A., Egervari, K., Freyschlag, C., Lobrinus, J. A., Migliorini, D., Momjian, S., Sanda, N., Schaller, K., Tran, S., Yeung, J., & Bijlenga, P. (2023). ChatGPT in glioma adjuvant therapy decision making: ready to assume the role of a doctor in the tumour board? BMJ Health & Care Informatics. https://doi.org/10.1136/bmjhci-2023-100775
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.